Literature DB >> 17013709

Living-donor liver transplantation: an overview.

Russell W Strong1.   

Abstract

It has been 16 years since the first successful living-donor liver transplant was performed from a parent to a child. The overall recipient and graft survival, together with a low morbidity and mortality in donors, have resulted in the widespread acceptance of the procedure by both the transplant community and the public at large. Adult-to-adult living-donor liver transplantation has been evolving over the past decade. Despite living-donor transplant patients being better-risk candidates than those who receive a graft from a deceased donor, and well-established and experienced units achieving satisfactory results, overall recipient and graft survival recorder by registries can only be described as suboptimal. This, combined with the high morbidity and not-insignificant mortality amongst donors makes expansion of adult-to-adult liver transplantation hard to justify on a risk-benefit analysis.

Entities:  

Mesh:

Year:  2006        PMID: 17013709     DOI: 10.1007/s00534-005-1076-y

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  10 in total

Review 1.  Biliary complications in living liver donors.

Authors:  Yufeng Yuan; Mitsukazu Gotoh
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

2.  Suramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver grafts.

Authors:  Songqing He; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Rick G Schnellmann; Zhi Zhong
Journal:  J Pharmacol Exp Ther       Date:  2012-11-16       Impact factor: 4.030

3.  Inhibition of inducible nitric oxide synthase prevents mitochondrial damage and improves survival of steatotic partial liver grafts.

Authors:  Songqing He; Hasibur Rehman; Gary L Wright; Zhi Zhong
Journal:  Transplantation       Date:  2010-02-15       Impact factor: 4.939

4.  NIM811 prevents mitochondrial dysfunction, attenuates liver injury, and stimulates liver regeneration after massive hepatectomy.

Authors:  Hasibur Rehman; Junjiang Sun; Yanjun Shi; Venkat K Ramshesh; Qinlong Liu; Robert T Currin; John J Lemasters; Zhi Zhong
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

5.  Russell Strong and the history of reduced-size liver transplantation.

Authors:  Guiseppe Garcea; Hajir Nabi; Guy J Maddern
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

Review 6.  Strategies to rescue steatotic livers before transplantation in clinical and experimental studies.

Authors:  Qiang Liu; Maria-Louisa Izamis; Hongzhi Xu; Tim Berendsen; Martin Yarmush; Korkut Uygun
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

7.  Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

Authors:  C E Freise; B W Gillespie; A J Koffron; A S F Lok; T L Pruett; J C Emond; J H Fair; R A Fisher; K M Olthoff; J F Trotter; R M Ghobrial; J E Everhart
Journal:  Am J Transplant       Date:  2008-10-24       Impact factor: 8.086

8.  Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts.

Authors:  Zhi Zhong; Shigeki Tsukada; Hasibur Rehman; Christopher J Parsons; Tom P Theruvath; Richard A Rippe; David A Brenner; John J Lemasters
Journal:  Liver Transpl       Date:  2010-02       Impact factor: 5.799

9.  Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999-2019.

Authors:  Sung Yeon Hong; Mee Joo Kang; Taegyu Kim; Kyu-Won Jung; Bong-Wan Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-08-08

10.  Research across the disciplines: a road map for quality criteria in empirical ethics research.

Authors:  Marcel Mertz; Julia Inthorn; Günter Renz; Lillian Geza Rothenberger; Sabine Salloch; Jan Schildmann; Sabine Wöhlke; Silke Schicktanz
Journal:  BMC Med Ethics       Date:  2014-03-01       Impact factor: 2.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.